Natural killer cell lymphoma/leukemia with homozygous loss of p27/kip1

REFERENCES

• Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Amoulet C, Baudouin FB, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson E, Husson B, Kuhlein E, Calvez GL, Sainty D, Sotto MF, Trimoreau F, Bene MC. Clinical and biologic features of CD4 + CD56 + malignancies. Blood 2002;99: 1556–1563.
   Google Scholar
• Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumors of hematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. pp. 214–215.
   Google Scholar
• Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clincopathologic and molecular features. Histol Histopathol 2002;17:593–554.
   Google Scholar
• Wong KF, Chan JK, Yu PH, So CC. A man with natural killer cell lymphoma showing 46, XX and deletion 6q. Cancer Genet Cytogenet 1999;112:165–168.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wong KF, Siebert R, Matthiesen P, Harder S, Eimermacher H, Feller AC, Schlegelberger B. Chromosome aberrations are restricted to the CD56 +, CD3- tumor cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study. Br J Haematol 1999;105:737–742.
   PubMed Web of Science ®Google Scholar
• Hamaguchi H, Yamaguchi M, Nagata K, Koike E, Imagunbai M, Tsurukubo Y, Yamamoto K. Aggressive natural killer cell lymphoma/leukemia with clonal der(3)t(1;3)(q12;p25), del(6)(q13) and del(13)(q12q14). Cancer Genet Cytogenet 2001;130: 150–154.
   Google Scholar
• Leroux D, Mugneret F, Callanan M, Weiss I, Dastugu N, Feuillard J, LeMee F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages MP, Mozziconacci MJ, Eclache V, Sibille C, Avet-Loiseau H, Pochitaloff ML, on behalf of Groupe Francais de Cytogenetique Hematologique (GFCH). CD4 +, CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 2002;99: 4154–4159.
   Google Scholar
• Mao X, Onadim Z, Price EA, Child F, Lillington DM, Russel R, Young BD, Wittaker S. Genomic alterations in blastic NK/ extranodal NK-like T-cell lymphoma with cutaneous involve-ment. J Invest Dermatol 2003;121:618–627.
   PubMed Web of Science ®Google Scholar
• Aissani B, Bonan C, Baccichet A, Sinnet D. Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3? Leukemia Lymphoma 1999;34:231–239.
   PubMed Web of Science ®Google Scholar
• Benzer R, Bernheim A, L,eConiat M, Vechione D, Pacot A, Daniel MT, Flandrim G. Abnormalities of the short arm of the chromosome 12 in acute non-lymphoblastic leukemia and dysmeylopoietic syndrome. Cancer Genet Cytogenet 1986;19: 281–289.
   Google Scholar
• Chan LC, Kwong YL, Lin HW, Lee CP, Chan AYY. Deletion 12p in de novo acute myeloid leukemia. Cancer Genet Cytogenet 1992;62: 47–49.
   Google Scholar
• Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Lin B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Vogelstein B. Assignment of the human p27Ikipl gene to 12p13 and its analysis in leukemia. Cancer Res 1995;55: 1206–1210.
   Google Scholar
• Siu LP, Wong KF, Chan JK, Kwong YL. Comparative genomic hybridization of natural killer cell lymphoma/leuke-mia. Recognition of consistent patterns of genetic alterations. Am J Pathol 1999;155:1419–1425.
   Google Scholar
• Gloub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translo-cation. Cell 1994;77:307–311.
   PubMed Web of Science ®Google Scholar
• Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M, Clurman BE. Identification of oncogenes collaborat-ing with p27Ikipl loss by insertional mutagenesis and high throughput insertion site analysis. PNAS 2002;99: 11293–11298.
   Google Scholar
• Martins CP, Berns A. Loss of p27 (Kipl) but not p21 (Cip 1 ) decreases survival and synergizes with MYC in murine lymphomagenesis. EMBO J 2002;21:3739–3748.
   PubMed Web of Science ®Google Scholar
• Morosetti R, Kawamata N, Gombart AF, Miller CW, Hatta Y, Hirama T, Said JW, Tomonaga M, Koeffier HP. Alterations of the p27Ikipl gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 1995;86: 1924–1930.
   Google Scholar
• Seriu T, Erz D, Bartam CR Germline configuration of the p27Ikipl gene in childhood acute lymphoblastic leukemia (ALL). Leukemia 1996;10:345.
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Bartam CR, Miller CW, Reiter A, Seriu T, Zimmermann M, Schrappe M, Mori N, Slater J, Miyoshi I, Koeffier HP. Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996;87: 3368–3374.
   Google Scholar
• Castanedo MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfield J, Massague J, Cardo CC. p27Ikipl: chromosomal mapping to 12p12-12p13.1 and absence of mutaions in human tumors. Cancer Res 1995;55: 1211–1214.
   Google Scholar
• Dahia PLM, Aguiar RCT, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM, Grossman AB. Mutation and expression analysis of the p27Ikipl gene in corticotrophin-secreting tumors. Oncogene 1998;16:69–76.
   PubMed Web of Science ®Google Scholar
• Roberts J. p27Ikipl: a haploinsufficient tumor suppressor. Kidney International 1999;56:1184.
   Web of Science ®Google Scholar
• Montpetit A, Boily G, Sinnet D. A detailed transcriptional map of the chromosome 12p12 tumor suppressor locus. Eur J Human Genet 2002;10: 62–71.
   Google Scholar
• Komuro H, Valentine MB, Rubnitz JE, Saito M, Raimondi JC, Carroll AJ, Yi T, Sherr CJ, Look AT. p27Ikipl deletions in childhood acute lymphoblastic leukemia. Neoplasia 1999;1: 253–261.
   Google Scholar
• Wong KF. Genetic changes in natural killer cell neoplasms. Leukemia Res 2002;26:977–978.
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee MH, Erdjument BH, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27Ikipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78: 59–66.
   Google Scholar
• Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359–393.
   PubMed Web of Science ®Google Scholar
• Philipp SJ, Payne SR, Kemp CJ. p27 (Kip 1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001;264: 148–168.
   Google Scholar
• Kuroda J, Kimura S, Kobayashi Y, Jyoko N, Kamitsuji Y, Murotani Y, Fukuda W, Akaogi T, Hayashi H, Yoshikawa T, Maekawa T. Variable manifestations in natural killer cell leukemia. Clin Lab Haem 2003;25:239–245.
   PubMedGoogle Scholar
• Moller MB, Skiodt K, Mortensen LS, Pedersen NT. Clinical significance of cyclin-dependent kinase inhibitor p27Kip 1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip 1 . Br J Haematol 1999;105:730–736.
   PubMed Web of Science ®Google Scholar